For better or worse, the economic and political conversation about the legalization of marijuana needs to be had. Why? Well, if majority rules — and that’s generally what happens in Democracy — then the short answer is: because the people demand it.
Demand may be an overstatement, but data compiled by Pew Research shows that a majority of Americans now think that marijuana should be made legal. Support for the legality of the drug increased 11 percentage points over the past 2 years to claim a 52 percent share of survey participants.
That said, this conversation may not be relevant to most investors for a few years to come. A national-level agreement on the legality of marijuana is still that far away. Ostensibly, one could seek out which company will have a first-mover advantage and invest in them early, even if this strategy is pretty much a pipe dream given how speculative it is.
As it stands, companies like Medical Marijuana, Inc. (MJNA.PK) or Cannabis Science, Inc. (CBIS.PK) represent the most legitimate business that somebody could choose to invest in. Medical Marijuana stock is trading at the center of a 52-week range between $0.02 and $0.50, and has a market cap of about $184 million.